Ottimo Pharma Raises over $140 Million in Series A Financing

Ottimo Pharma United Kingdom United States of America Massachusetts

Financing led by OrbiMed, Avoro Capital, and Samsara BioCapital, with additional investment from founding investor MedicxiStrengthens its leadership team with the appointments of industry veterans Rick Anderson as SVP Finance, Spencer Fisk as Chief Technical and Quality Officer, and Ling Zeng as General Counsel and EVP of Execution IND-enabling studies underway for first-in-class PD1/VEGFR2 bifunctional antibody View original content:https://www.prnewswire.co.uk/news-releases/ottimo-pharma-raises-over-140-million-in-series-a-financing-302335272.html